ArticleCancer management and research2026
The Luo-Dingyuan Thyroid Vascular-Lymphatic Segmentation Classification: A Functional Anatomy-Based Framework to Facilitate Precision Management and Thyroid Function Preservation.
Article in Cancer management and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypothyroidism remains a common and clinically significant consequence of thyroid surgery, frequently necessitating long-term or lifelong thyroid hormone replacement therapy, which may be associated with adverse effects on cardiovascular health and bone metabolism. In the era of treatment de-escalation, active surveillance and local ablation have emerged as important management. However, both require precise anatomical localization and rational definition of treatment boundaries. Therefore, a precise anatomical framework that enables function-preserving management without compromising oncologic safety is urgently needed. The study proposes and comprehensively describes a novel, anatomy-based segmental classification of thyroid, the Luo-Dingyuan Segmental Classification (Luo Segmental Classification), to explore its potential clinical applications. Methods: The Luo Segmental Classification was developed through an integrated analysis of classical thyroid anatomy, vascular territories, and lymphatic drainage patterns. Each thyroid lobe is divided longitudinally into upper, middle, and lower thirds and further subdivided into anterior and posterior segments according to depth and vascular-lymphatic orientation, resulting in six reproducible segments per lobe. The isthmus and pyramidal lobe are defined as an independent anatomical unit. Potential clinical applications were evaluated conceptually in imaging, surgery, active surveillance, and ablation. Results: The thyroid can be consistently divided into anatomically and functionally meaningful segments corresponding to distinct vascular and lymphatic territories. Based on this principle, the classification enabled standardized anatomical localization of thyroid nodules across ultrasonography (US), computed tomography (CT), and magnetic resonance imaging (MRI). Segment-based localization allowed precise description of tumor position, facilitated individualized treatment planning, and provided a unified anatomical language bridging radiology, surgery, pathology, and interventional therapy. Overall, this framework supported standardized reporting, individualized management, and potential reduction of unnecessary thyroid tissue loss and permanent hypothyroidism. Conclusion: The Luo Segmental Classification provides an anatomy-based framework to promote precise and individualized management of thyroid cancer, support function-preserving strategies, and address unmet clinical needs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.